REAL world efficacy and safety analysis of pembrolizumab KEY truda
Latest Information Update: 01 Oct 2021
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms REAL-KEY
- 01 Oct 2021 New trial record